Skip to Main Content

Paper Details

Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax.
Leuk Lymphoma
10
2022
AFP, AML, IFI, IFIs, Mycoses, VEN, acute myeloid leukemia, fungal infections, invasive fungal infections, patients, venetoclax
Author NameAffiliation
Eric P WinerDana-Farber Cancer Institute
Robert Coleman LindsleyDana-Farber Cancer Institute
Donna NeubergDana-Farber Cancer Institute
Daniel J DeAngeloDana-Farber Cancer Institute
Richard M StoneDana-Farber Cancer Institute
Marlise R LuskinDana-Farber Cancer Institute
  • 1 - 6

Datasets

Release 1.2